ADC Therapeutics SA (ADCT)
1.59
-0.17 (-9.66%)
At close: Mar 03, 2025, 3:59 PM
1.62
1.57%
After-hours: Mar 03, 2025, 06:50 PM EST
ADC Therapeutics SA Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 278.6M | 326.44M | 466.54M | 439.19M | 115.55M | 138.81M | 262.75M | 143.67M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.65M | 31.15M | 41.24M | 47.91M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 711K | 903K | 693K | 397K | 368K | 264K | 232K | 134K |
Receivables | 25.18M | 72.97M | 30.22M | n/a | n/a | 192K | 1.93M | 5.91M |
Inventory | 16.18M | 18.56M | 11.12M | 6.5M | 2.47M | 1.2M | 293K | n/a |
Other Current Assets | 16.33M | 23.5M | 17.3M | 11.26M | 4.21M | 1.38M | 394K | 1.68M |
Total Current Assets | 336.29M | 446.01M | 525.18M | 450.45M | 122.61M | 142.08M | 265.17M | 151.25M |
Property-Plant & Equipment | 16.13M | 9.98M | 11.23M | 4.76M | 6.27M | 1.54M | 1.14M | 777K |
Goodwill & Intangibles | n/a | 14.36M | 13.58M | 10.18M | 8.43M | 6.67M | 5.4M | 2.91M |
Total Long-Term Assets | 18.49M | 83.15M | 92.79M | 63.24M | 15.08M | 8.48M | 6.78M | 3.82M |
Total Assets | 354.78M | 529.17M | 617.97M | 513.69M | 137.68M | 150.56M | 271.95M | 155.08M |
Account Payables | 15.57M | 12.35M | 12.08M | 5.28M | 3.33M | 6.75M | 7.62M | 2.15M |
Deferred Revenue | n/a | n/a | 3.75M | 149K | n/a | 1.76M | 2.32M | 1.84M |
Short-Term Debt | 1.47M | 1.1M | 8.63M | 5.63M | 1.13M | n/a | n/a | n/a |
Other Current Liabilities | 50.63M | 68.49M | 49.47M | 29.37M | 15.43M | 13.63M | 10.41M | 5.42M |
Total Current Liabilities | 67.67M | 98.96M | 73.94M | 40.44M | 19.94M | 22.35M | 20.55M | 9.67M |
Long-Term Debt | 122.91M | 116.28M | 132.09M | 37.24M | 3.9M | n/a | n/a | n/a |
Other Long-Term Liabilities | 312.45M | 838K | 3.65M | 76.97M | 2.68M | 1.39M | 1.08M | 1.07M |
Total Long-Term Liabilities | 435.36M | 341.48M | 377.95M | 137.75M | 6.58M | 1.96M | 2.24M | 4.51M |
Total Liabilities | 503.03M | 440.44M | 451.88M | 178.19M | 26.53M | 24.32M | 22.78M | 14.18M |
Total Debt | 124.38M | 117.38M | 101.75M | 41.87M | 5.03M | n/a | n/a | n/a |
Common Stock | 7.31M | 7.31M | 6.45M | 6.31M | 4.36M | 401K | 397K | 334K |
Retained Earnings | -1.34B | -1.08B | -924.88M | -694.86M | -448.57M | -332.08M | -208.99M | -119.13M |
Comprehensive Income | -93K | 155.33M | 102.83M | 43M | 5.54M | 5.66M | 5.46M | 4.57M |
Shareholders Equity | -148.25M | 88.73M | 166.09M | 335.5M | 111.16M | 126.24M | 249.17M | 140.89M |
Total Investments | 1.65M | 31.15M | 41.24M | 47.91M | n/a | n/a | n/a | n/a |